Condition

Midgut Neuroendocrine Tumours (1)

Pancreatic Tumours (1)

Overall Status

Completed (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

Ipsen (1)

Collaborator

Intervention

lanreotide autogel 120 mg (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

pancreatic tumours

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Pancreatic Tumours, Midgut Neuroendocrine Tumours Trial in Worldwide (Lanreotide autogel 120 mg)

Completed

Pancreatic Tumours
Midgut Neuroendocrine Tumours

Lanreotide autogel 120 mg

Bruxelles, Belgium
+31 more

Dec 4, 2020